title: ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.
abstract: This topic addresses the management of recurrent Hodgkin lymphoma. While autologous stem cell transplantation may be appropriate for select cases of recurrent disease following comprehensive combined-modality therapy, other options exist for patients treated with lower-dose therapy for early-stage disease. Additionally, innovative targeted therapies provide newer salvage options to consider. The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation, or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. By combining the most recent medical literature and expert opinion, this revised guideline can aid clinicians in the complex decision-making associated with the management of recurrent Hodgkin lymphoma.
authors.forename: Karen M
authors.initials: KM
authors.lastname: Winkfield
authors.forename: Ranjana H
authors.initials: RH
authors.lastname: Advani
authors.forename: Leslie K
authors.initials: LK
authors.lastname: Ballas
authors.forename: Bouthaina S
authors.initials: BS
authors.lastname: Dabaja
authors.forename: Sughosh
authors.initials: S
authors.lastname: Dhakal
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Flowers
authors.forename: Chul Soo
authors.initials: CS
authors.lastname: Ha
authors.forename: Bradford S
authors.initials: BS
authors.lastname: Hoppe
authors.forename: David B
authors.initials: DB
authors.lastname: Mansur
authors.forename: Nancy P
authors.initials: NP
authors.lastname: Mendenhall
authors.forename: Monika L
authors.initials: ML
authors.lastname: Metzger
authors.forename: John P
authors.initials: JP
authors.lastname: Plastaras
authors.forename: Kenneth B
authors.initials: KB
authors.lastname: Roberts
authors.forename: Ronald
authors.initials: R
authors.lastname: Shapiro
authors.forename: Sonali M
authors.initials: SM
authors.lastname: Smith
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Terezakis
authors.forename: Anas
authors.initials: A
authors.lastname: Younes
authors.forename: Louis S
authors.initials: LS
authors.lastname: Constine
mesh_terms: D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D012008:Recurrence; D014182:Transplantation, Autologous